Medical Developments International Limited
MVP
Rank in Stocks
#27327
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Share Price
$0.28564034
Last synced: 2026-10-16
Market Cap
$32.18M
Change (1 day)
0.62%
Change (1 year)
-10.90%
Country
AU
Trade Medical Developments International Limited (MVP)
Category
Healthcare
Market Capitalization of Medical Developments International Limited(MVP)
Market Cap: $32.18M
As of October 2026 Medical Developments International Limited has a market cap of $32.18M. This makes Medical Developments International Limited the world's 27327th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Medical Developments International Limited from 2020 to 2026
MVP compared with Top 5 Most Popular stocks
